GlassScriptPhysician profile
Sheridan Jansen
NPI 1104531474
$1,885.56
in general payments reported to CMS, 2019-2025
19 companies · $758 in 2025
The $758 reported for 2025 was more than what 79% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $288 · 2024: $839 · 2025: $758.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,886.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,885.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $738.35 | 2024-2025 | |
| Galderma Laboratories, L.P. | $286.57 | 2023-2025 | |
| Merz North America, INC. | $146.67 | 2023 | Xeomin |
| Ucb, INC. | $134.73 | 2024-2025 | Bimzelx |
| Novartis Pharmaceuticals Corporation | $113.28 | 2024-2025 | |
| Janssen Biotech, INC. | $50.54 | 2024-2025 | Tremfya |
| Incyte Corporation | $47.50 | 2025 | Opzelura |
| Regeneron Healthcare Solutions, INC. | $46.25 | 2024-2025 | Libtayo, Dupixent |
| Dermavant Sciences, INC. | $45.37 | 2024 | Vtama |
| Arcutis Biotherapeutics, INC. | $44.16 | 2024 | Zoryve |
| Sun Pharmaceutical Industries INC. | $41.37 | 2025 | |
| Botanix Sb INC | $40.11 | 2025 | Sofdra |
| Genzyme Corporation | $34.83 | 2024 | |
| Pfizer INC. | $34.73 | 2025 | |
| Kyowa Kirin, INC. | $29.24 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $18.31 | 2025 | Jublia |
| Amgen INC. | $16.71 | 2025 | Otezla |
| Leo Pharma INC. | $13.75 | 2025 | Adbry |
| Organon LLC | $3.09 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheridan Jansen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.